Debut Biotech is a biotechnology company that focuses on developing a platform for cell-free biocatalysis. It specializes in creating a range of immobilized enzymes for use in manufacturing systems: biomanufacturing cartridges, fermentation, immobilization of cells and enzymes and enzymes for pharmaceutical production and modification.
|HQ||San Diego, CA, US||Map|
|Employees (est.) (Jun 2021)||16|
Debut Biotech total Funding
Debut Biotech latest funding size
Time since last funding
|a year ago|
Debut Biotech investors
|Better Ventures, Springtide Ventures, KdT Ventures, FTW Ventures|
When was Debut Biotech founded?
Debut Biotech was founded in 2019.
Who are Debut Biotech key executives?
Debut Biotech's key executives are Joshua Britton, Gregory Weiss and Nick Brideau.
How many employees does Debut Biotech have?
Debut Biotech has 16 employees.
Who are Debut Biotech competitors?
Competitors of Debut Biotech include VectorBuilder, Tenaya Therapeutics and iMotions.
Where is Debut Biotech headquarters?
Debut Biotech headquarters is located at 10210 Campus Point Dr, San Diego.
Where are Debut Biotech offices?
Debut Biotech has an office in San Diego.
How many offices does Debut Biotech have?
Debut Biotech has 1 office.
Receive alerts for 300+ data fields across thousands of companies